Nemolizumab for Lichen Sclerosus
What You Need to Know Before You Apply
What is the purpose of this trial?
Patients ≥ 18 years of age with Lichen sclerosis (LS)
Who Is on the Research Team?
Melissa Mauskar, MD
Principal Investigator
University of Texas Southwestern Medical Center
Are You a Good Fit for This Trial?
This trial is for adults aged 18 or older who have been diagnosed with lichen sclerosus, a chronic skin condition affecting the vulva. People with other major health issues or certain infections may not be able to join.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Nemolizumab
Trial Overview
The study is testing Nemolizumab, given as a 30 mg dose, to see if it helps treat symptoms of lichen sclerosus and related vulvar conditions in adult patients.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants will be treated with subcutaneous (SC) nemolizumab injections
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas Southwestern Medical Center
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.